COVID-19: US Govt Gobbles Up 150 Million BinaxNOW Rapid Tests From Abbott
Abbott will be paid $760m for the tests under a contract with the Department of Health and Human Services and the Department of Defense.
You may also be interested in...
Cue’s point-of-care molecular test earned an FDA emergency use authorization in June.
The BinaxNOW COVID-19 Ag Card portable lateral flow test, which delivers rapid results with no instrumentation, could be a “game changer” in the effort to reopen schools and other crowded places.
A 5 May report from the US FDA says that even under the best COVID-19 conditions the agency’s inspections of makers of medical and tobacco products will likely be cut in half this year. The FDA also announced it will launch an agency-wide Inspectional Affairs Council to “plan and coordinate inspectional activities.”